TY - JOUR
T1 - Oxidative stress based-biomarkers in oral carcinogenesis: how far have we gone?
AU - Hanafi, Rania
AU - Anestopoulos, Ioannis
AU - Voulgaridou, Georgia-Persephoni
AU - Franco, Rodrigo
AU - Georgakilas, Alexandros G
AU - Ziech, Dominique
AU - Malamou-Mitsi, Vasiliki
AU - Pappa, Aglaia
AU - Panayiotidis, Mihalis I
PY - 2012/7
Y1 - 2012/7
N2 - Oral cancer accounts for 2-3% of all malignancies and according to the World Health Organization (WHO) is the fifth most common cancer worldwide. On the other hand, "oxidative stress" implies a cellular state whereby reactive oxygen species (ROS) production exceeds its metabolism resulting in excessive ROS accumulation and overwhelmed cellular defenses. Such a state has been shown to be involved in the multistage process of human carcinogenesis (including oral cancer) via many different mechanisms. Amongst them are ROS-induced oxidative modifications on major cellular macromolecules like DNA, proteins and lipids with the resulting byproducts being involved in the pathophysiology of human oral malignant and pre-malignant lesions. Throughout this manuscript, we review the current state of knowledge on the role of these oxidative-modified cellular byproducts in serving as reliable biomarkers for oral cancer detection, prognosis and diagnosis.
AB - Oral cancer accounts for 2-3% of all malignancies and according to the World Health Organization (WHO) is the fifth most common cancer worldwide. On the other hand, "oxidative stress" implies a cellular state whereby reactive oxygen species (ROS) production exceeds its metabolism resulting in excessive ROS accumulation and overwhelmed cellular defenses. Such a state has been shown to be involved in the multistage process of human carcinogenesis (including oral cancer) via many different mechanisms. Amongst them are ROS-induced oxidative modifications on major cellular macromolecules like DNA, proteins and lipids with the resulting byproducts being involved in the pathophysiology of human oral malignant and pre-malignant lesions. Throughout this manuscript, we review the current state of knowledge on the role of these oxidative-modified cellular byproducts in serving as reliable biomarkers for oral cancer detection, prognosis and diagnosis.
U2 - 10.2174/156652412800792598
DO - 10.2174/156652412800792598
M3 - Article
SN - 1566-5240
VL - 12
SP - 698
EP - 703
JO - Current Molecular Medicine
JF - Current Molecular Medicine
IS - 6
ER -